RecruitingPhase 1NCT07001930

Effects of Cannabidiol on Stress and Nicotine Withdrawal

Pharmacological Effects of Cannabidiol on Responses to Stress and Nicotine Withdrawal


Sponsor

Johns Hopkins University

Enrollment

90 participants

Start Date

Aug 25, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to examine the effect of doses of cannabidiol (CBD) during exposure to stress and nicotine withdrawal in nicotine users. The main objectives of the study include examining the effect CBD has on stress, tobacco dependence, tobacco withdrawal, and sex differences between these types of stress. Participants will be administered CBD and exposed to stress. Biological and subjective measures will be collected. Participants may be asked to stop use for 24 hours. Researchers will also investigate withdrawal effects between participants who have not smoked nicotine in 24 hours and those who have continued to smoke before each session.


Eligibility

Min Age: 21 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Epidiolex for people with cbd, nicotine dependence, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 21 Years to 70 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGEpidiolex

Oral cannabidiol


Locations(1)

Behavioral Pharmacology Research Unit

Baltimore, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07001930


Related Trials